IFNA1 and hepatocellular carcinoma: NFATc3 was found to impede HCC and hepatitis B virus replication by positively regulating RIG-I-mediated IFN transcription, illustrating that NFATc3 may exert an effect on the RIG-I pathway, which is vital for maintaining liver health and repressing viral replication (85).